What is the target LDL cholesterol level for a patient without a personal history of coronary artery disease but with a strong family history of heart disease in his father and both grandfathers, none of whom had early‑onset disease?

LDL-C Goal for Patient Without Personal CAD but Strong Family History (Non-Early Onset)

For a patient without personal history of coronary artery disease but with a strong family history of heart disease that is NOT early-onset, the LDL-C goal should be <100 mg/dL (2.6 mmol/L), placing this patient in the HIGH cardiovascular risk category.

Risk Stratification

This patient does NOT qualify as "very high risk" because:

• No documented cardiovascular disease
• Family history is NOT early-onset (early onset defined as <55 years in men, <60-65 years in women) 1, 2, 1
• Family history alone, when not premature, is considered a risk-enhancing factor but does not automatically elevate to very high risk 3

The patient should undergo formal cardiovascular risk assessment using a risk estimation system such as SCORE (for European guidelines) or the Pooled Cohort Equation (for US guidelines) 1, 2, 1. Based on this assessment, the patient will likely fall into the HIGH risk category rather than very high risk.

Treatment Target

The LDL-C goal for HIGH cardiovascular risk patients is <2.6 mmol/L (100 mg/dL), or a reduction of at least 50% if baseline LDL-C is between 2.6-5.2 mmol/L (100-200 mg/dL) 1, 2, 1.

This is distinct from very high-risk patients (those with established ASCVD, diabetes with target organ damage, or familial hypercholesterolemia) who have a more aggressive target of <1.8 mmol/L (70 mg/dL) 1, 2.

Treatment Approach

1. Initiate statin therapy as first-line treatment to reach the LDL-C goal, using up to the highest recommended or tolerable dose 1

2. If LDL-C remains ≥100 mg/dL after 4-6 weeks on statin monotherapy, add ezetimibe to achieve target 4

3. Lifestyle modifications should be implemented concurrently, including dietary changes (reduce saturated fat to <7% of calories, cholesterol intake <200 mg/day), regular physical activity, and weight management if needed 5

Important Caveats

• If the patient has additional risk-enhancing factors (metabolic syndrome, chronic kidney disease, elevated Lp(a) >50 mg/dL, high-sensitivity CRP ≥2.0 mg/L, or persistently elevated triglycerides), consider more intensive therapy or closer monitoring 3

• The distinction between "strong family history" and "early-onset family history" is critical—only early-onset family history (men <55 years, women <60-65 years) significantly elevates risk stratification 1, 2, 5, 1

• Do not confuse this patient with familial hypercholesterolemia, which requires LDL-C >190 mg/dL in adults or specific clinical criteria including tendon xanthomas 1, 2, 1

• Regular monitoring every 4-6 weeks during titration, then annually once target is achieved, is essential for ensuring adherence and target attainment 4